CIK: 0001602263
申报总市值
US$3.8亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | 股票-其他 | 27.68% | — | — | |
| 2 | BHVN | Biohaven Ltd. | 股票-其他 | 16.81% | -4.69% | — | |
| 3 | ASND | Ascendis Pharma A/S | 股票-其他 | 13.01% | -8.61% | EXIT | |
| 4 | ZGNXEUR | Zogenix INC | 股票-其他 | 8.78% | — | — | |
| 5 | ✓ | DBV Technologies | 股票-其他 | 6.18% | — | — | |
| 6 | BCRX | Biocryst Pharmaceuticals INC | 股票-其他 | 4.58% | -3.14% | EXIT | |
| 7 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 4.00% | — | — | |
| 8 | EWTX | Edgewise Therapeutics, Inc. | 股票-其他 | 3.79% | — | -33.84% | |
| 9 | ✓ | Obseva SA | 股票-其他 | 3.15% | -5.57% | +834.23% | |
| 10 | MYOKEUR | Myokardia INC | 股票-其他 | 3.14% | — | — | |
| 11 | RARXEUR | Ra Pharmaceuticals INC | 股票-其他 | 3.11% | -6.10% | EXIT | |
| 12 | ANAB | Anaptysbio INC | 股票-其他 | 1.62% | — | — | |
| 13 | BLPHEUR | Bellerophon Therapeutics INC | 股票-其他 | 1.30% | -0.70% | — | |
| 14 | ✓ | 股票-其他 | 0.72% | — | — | ||
| 15 | ✓ | Lipocine INC New | 股票-其他 | 0.42% | — | — | |
| 16 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 0.41% | +0.05% | — | |
| 17 | MDGL | Madrigal Pharmaceuticals INC | 股票-医疗保健 | 0.37% | — | — | |
| 18 | ✓ | ARCA biopharma Inc | 股票-其他 | 0.34% | — | — | |
| 19 | ADVMCHF | Adverum Biotechnologies INC | 股票-其他 | 0.28% | +1.16% | NEW | |
| 20 | ✓ | Ocera Therapeutics INC | 股票-其他 | 0.15% | — | -60.81% | |
| 21 | ✓ | Axovant Sciences LTD | 股票-其他 | 0.14% | — | -74.76% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ✓ | Obseva SA | +2.6% | +834.23% | 加仓 |
| 2 | ASND | Ascendis Pharma A/S | +2.1% | +31.68% | 加仓 |
| 3 | BHVN | Biohaven Ltd. | +1.7% | — | 不变 |
| 4 | ADVMCHF | Adverum Biotechnologies INC | — | — | 不变 |
| 5 | ✓ | -0.1% | — | 不变 | |
| 6 | ✓ | Lipocine INC New | -0.2% | — | 不变 |
| 7 | 4XC1 | Kalvista Pharmaceuticals INC | -0.2% | — | 不变 |
| 8 | ✓ | Ocera Therapeutics INC | -0.4% | -60.81% | 减仓 |
| 9 | ✓ | ARCA biopharma Inc | -0.7% | — | 不变 |
| 10 | BCRX | Biocryst Pharmaceuticals INC | -0.9% | +27.89% | 加仓 |
| 11 | ✓ | DBV Technologies | -1.4% | — | 不变 |
| 12 | ARGX | Argenx Se - Adr | -1.4% | — | 不变 |
| 13 | ✓ | Axovant Sciences LTD | -2.7% | -74.76% | 减仓 |
| 14 | RARXEUR | Ra Pharmaceuticals INC | -2.7% | — | 不变 |
| 15 | ✓ | Avexis INC | -3.1% | — | 不变 |
| 16 | EWTX | Edgewise Therapeutics, Inc. | -4.1% | -33.84% | 减仓 |
| 17 | ZGNXEUR | Zogenix INC | — | NEW | 新建仓 |
| 18 | MYOKEUR | Myokardia INC | — | NEW | 新建仓 |
| 19 | ANAB | Anaptysbio INC | — | NEW | 新建仓 |
| 20 | XLRN | Acceleron Pharma INC | — | EXIT | 清仓 |
| 21 | BLPHEUR | Bellerophon Therapeutics INC | — | NEW | 新建仓 |
| 22 | CTMX | Cytomx Therapeutics INC | — | EXIT | 清仓 |
| 23 | MDGL | Madrigal Pharmaceuticals INC | — | NEW | 新建仓 |
| 24 | SRRAEUR | Sierra Oncology INC | — | EXIT | 清仓 |